Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis

Abstract

Complementary and alternative medicine (CAM) use is high among people with multiple sclerosis (MS), yet there are no reports on the association between CAM use and health-related quality of life (HRQL) in MS. To examine this relationship, a cross-sectional survey and SF-12 was used to collect demographic and HRQL data from 1667 survey respondents. Factors examined for their association with CAM use included, age, gender, race, self-reported disease severity, disease-modifying drug (DMT) use, MS duration, MS type, education level, physical and mental well-being. Multiple regression analysis revealed that female gender, high education level, longer MS duration, lower physical well-being and not using DMT were independent factors associated with both ‘ever’ and ‘current’ CAM use. The finding that a drop in physical component score (PCS) of the SF-12 is independently associated with an increased odds of ‘ever’ CAM use, ‘current’ CAM use, and ‘past’ CAM reflect an association of CAM use with PCS regardless of time of use. Although, temporality of this relationship cannot be established, as this was a cross-sectional study, a longitudinal study is warranted so that we can establish if HRQL is predictive for CAM use in MS.

Keywords

complementary medicine health survey multiple sclerosis quality of life

Get full access to this article

View all access options for this article.

References

Berkman C , Pignotti M , Cavallo P , Holland N. Use of alternative treatments by people with multiple sclerosis . Neurorehabil Neural Rep 1999; 13: 243-254 .

Schwartz CE , Laitin E , Brotman S , LaRocca N. Utilization of unconventional treatments by persons with MS: is it alternative or complementary ? Neurology 1999; 52: 626-629 .

Nayak S , Matheis RJ , Schoenberger NE , Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis . Clin Rehabil 2003; 17: 181-191 .

Marrie RA , Hadjimichael O , Vollmer T. Predictors of alternative medicine use by multiple sclerosis patients . Mult Scler 2003; 9: 461-466 .

Page SA , Verhoef MJ , Stebbins RA , Metz LM , Levy CL. The use of complementary and alternative therapies by people with multiple sclerosis . Chronic Dis Can 2003; 24: 75-79 .

Stuifbergen AK , Harrison TC. Complementary and alternative therapy use in persons with multiple sclerosis . Rehabil Nurs 2003; 28: 141-147 .

Astin JA. Why patients use alternative medicine: results of a national study . JAMA 1998; 279: 1548-1553 .

Nortvedt MW , Riise T. The use of quality of life measures in multiple sclerosis research . Mult Scler 2003; 9: 63-72 .

Ware J , Kosinski M , Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity . Med Care 1996; 34: 220-233 .

10.

Vollmer TL , Hadjimichael O , Preiningerova J , Ni W , Buenconsejo J. Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans . J Rehabil Res Dev 2002; 39: 163-174 .

11.

Hohol MJ , Orav EJ , Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression . Mult Scler 1999; 5: 349-354 .

12.

Hosmer D , Lemeshow S. Applied logistic regression, second edition. Wiley series in probability and statistics. John Wiley and Sons, Inc. , 2000: 147-156.

13.

Gray CM , Tan AW , Pronk NP , O’Connor PJ. Complementary and alternative medicine use among health plan members. A cross-sectional survey . Eff Clin Pract 2002; 5: 17-22 .

14.

Ong CK , Petersen S , Bodeker GC , Stewart-Brown S. Health status of people using complementary and alternative medical practitioner services in 4 English counties . Am J Publ Health 2002; 92: 1653-1656 .

15.

Bausell RB , Lee WL , Berman BM. Demographic and health-related correlates to visits to complementary and alternative medical providers . Med Care 2001; 39: 190-196 .

16.

Miller DM , Rudick RA , Baier M , Cutter G , Dough-tery DS , Weinstock-Guttman B et al. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis . Mult Scler 2003; 9: 1-5 .

17.

Chang CH , Cella D , Fernandez O , Luque G , de Castro P , de Andres C et al. Quality of life in multiple sclerosis patients in Spain . Mult Scler 2002; 8: 527-531 .

18.

Nortvedt MW , Riise T , Myhr KM , Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly . Neurology 1999; 53: 1098-1103 .

19.

Jain N , Astin JA. Barriers to acceptance: an exploratory study of complementary/alternative medicine disuse . J Altern Complement Med 2001; 7: 689-696 .

20.

Nortvedt MW , Riise T , Myhr KM , Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population . Med Care 2000; 38: 1022-1028 .

21.

Gandek B , Ware JE , Aaronson NK , Apolone G , Bjorner JB , Brazier JE et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment . J Clin Epidemiol 1998; 51: 1171-1178

22.

Schwartz CE , Vollmer T , Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group . Neurology 1999; 52: 63-70 .

23.

Hobart JC , Riazi A , Lamping DL , Fitzpatrick R , Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12) . Neurology 2003; 60: 31-36 .

24.

Filippini G , Munari L , Incorvaia B , Ebers GC , Polman C , D’Amico R et al. Interferons in relapsing remitting multiple sclerosis: a systematic review . Lancet 2003; 361: 545-552 .